veliparib

AstraZeneca strengthens lead in PARP drug class
Biopharma Dive
Sat, 09/28/19 - 05:00 pm
AstraZeneca
Merck
Lynparza
ovarian cancer
PARP inhibitors
veliparib
Failure Of Abbvie's Cancer Drug Hasn't Hurt The Stock
Barron's
Fri, 04/21/17 - 11:28 am
AbbVie
veliparib
AbbVie breast cancer drug falls short in Phase 2
BioPharma Dive
Wed, 12/7/16 - 07:45 pm
AbbVie
breast cancer
veliparib
PARP inhibitors
BRCA-mutant breast cancer
AbbVie Receives FDA Orphan Drug Designation for Investigational Medicine Veliparib for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Yahoo
Sat, 11/5/16 - 02:10 pm
AbbVie
veliparib
advanced squamous non-small cell lung cancer
AbbVie Candidate in Pivotal Study
Yahoo/Zacks.com
Thu, 04/17/14 - 11:51 am
AbbVie
veliparib
non-small cell lung cancer
AbbVie initiates Phase III clinical trial of veliparib in lung cancer
The Fly on the Wall
Tue, 04/15/14 - 10:09 am
AbbVie
clinical trials
veliparib
non-small cell lung cancer
AbbVie Advances with Cancer Candidate
Yahoo/Zacks.com
Thu, 01/16/14 - 09:31 am
AbbVie
veliparib
triple-negative breast cancer
AbbVie drug shows promise against difficult type of breast cancer
Reuters
Fri, 12/13/13 - 10:31 am
AbbVie
veliparib
triple-negative breast cancer